SWISS PHARMACEUTICAL WHOLESALER
IMPORT AND EXPORT OF MEDICINAL PRODUCTS
INTERNATIONAL PHARMACEUTICAL TRADING
Swiss Global Pharma, a swiss company headquartered in Lugano established in 2007, is a Swiss leader in import and distribution of pharmaceutical and medical products from and to any part of the world.
We can supply a wide range of Swiss and international medicines to all authorized professionals, companies, hospitals and other healthcare institutions. We have access to the newest lifesaving drugs approved by the US FDA and/or Swissmedic (the Swiss Health Authority). We are specialized in sourcing orphan drugs and new approved
pharmaceuticals. Swiss quality and a global approach compliant to international regulations are among our most distinctive features.
As a result we are able to ensure supply chain integrity from the validation of the pharmaceutical product's origin, through the transportation and storage until the delivery to our clients. Swiss Global Pharma has been certified as compliant with the "Good Distribution Practices" requirements of Swissmedic.
the most requested products
Keytruda (pembrolizumab) is a human PD-1 (programmed death receptor-1)-blocking antibody indicated for the treatment of melanoma, non-small cell lung cancer, head and neck squamous cell carcinoma, classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, urothelial carcinoma, microsatellite instability-high cancer, gastric cancer, cervical cancer, hepatocellular carcinoma, and Merkel cell carcinoma.
MabThera is the first therapeutic monoclonal antibody to target cells that have the CD20 marker on their surface. These cells are central to many blood cancers, including common forms of lymphoma and leukaemia. MabThera attacks these cells both directly and together with the body’s immune system.